Advances on selective laser trabeculoplasty

doi:10.3877/cma.j.issn.2095-2007.2022.04.009

Abstract

Abstract:

Glaucoma is the leading cause of irreversible blindness in the whole world. The basic treatment methods for glaucoma are concentrated on the intraocular pressure reduction by medication, laser and surgery. Selective laser trabeculectomy (SLT) is performed by using a Q-switched, frequency-doubled Nd: YAG laser at 532 nm wave length, which selectively acts on pigmentary trabecular tissue to reduce intraocular pressure. Over the past three decades, it has been demonstrated that SLT has become a safe and effective option of the alternative or initial treatments for various types of glaucoma, mainly primary open-angle glaucoma, because of intraocular pressure reduction with absent or minimal structural damage to the trabecular meshwork. The history of SLT, mechanisms of action, clinical application, initial treatment, repeat treatment, predictive factors of treatment success, complications and adverse reactions, cost-effectiveness, and health-related quality of life were reviewed in this paper.

Key words: Selective laser trabeculoplasty, Glaucoma, Intraocular pressure, Trabecular meshwork

Yipeng Shi, Wenying Sun, Like Xie, Xiaobin Xie. Advances on selective laser trabeculoplasty[J]. Chinese Journal of Ophthalmologic Medicine(Electronic Edition), 2022, 12(04): 237-241.

/ / Recommend

Add to citation manager EndNote|Ris|BibTeX

URL: https://zhykyxzz.cma-cmc.com.cn/EN/10.3877/cma.j.issn.2095-2007.2022.04.009

https://zhykyxzz.cma-cmc.com.cn/EN/Y2022/V12/I04/237

References 55

[1]	Tham YC, Li X, Wong TY, et al. Global prevalence of glaucoma and projections of glaucoma burden through 2040[J]. Ophthalmology, 2014, 121(11): 2081－2090.
[2]	Gazzard G, Konstantakopoulou E, Garway－Heath D, et al. Selective laser trabeculoplasty versus eye drops for first－line treatment of ocular hypertension and glaucoma (LiGHT): a multicentre randomised controlled trial[J]. Lancet, 2019, 393(10180): 1505－1516.
[3]	Krasnov MM. Laseropuncture of anterior chamber angle in glaucoma[J]. Am J Ophthalmol, 1973, 75(4): 674－678.
[4]	Wise JB, Witter SL. Argon laser therapy for open－angle glaucoma. A pilot study[J]. Arch Ophthalmol, 1979, 97(2): 319－322.
[5]	Anderson RR, Parrish JA. Selective photothermolysis: precise microsurgery by selective absorption of pulsed radiation[J]. Science, 1983, 220(4596): 524－527.
[6]	Latina MA, Park C. Selective targeting of trabecular meshwork cells: in vitro studies of pulsed and CW laser interactions[J]. Exp Eye Res, 1995, 60(4): 359－371.
[7]	Latina MA, Sibayan SA, Shin DH, et al. Q－switched 532－nm Nd: YAG laser trabeculoplasty (selective laser trabeculoplasty): a multicenter, pilot, clinical study[J]. Ophthalmology, 1998, 105(11): 2082－2090.
[8]	谭海波，祝丽娜，沈洁. 选择性激光小梁成形术联合药物治疗在开角型青光眼中的应用[J]. 上海交通大学学报(医学版)，2015，35(12)：1858－1861，1866.
[9]	张洪洋，叶一明，杨扬帆，等. 选择性激光小梁成形术的激光效应对体外小梁细胞MMP－3及MMP－9表达的影响[J]. 中华实验眼科杂志，2015，33(3)：227－231.
[10]	Lee JW, Wong MO, Liu CC, et al. Optimal selective laser trabeculoplasty energy for maximal intraocular pressure reduction in open－angle glaucoma[J]. J Glaucoma, 2015, 24(5): e128－131.
[11]	Nirappel A, Klug E, Ye R, et al. Effectiveness of Selective Laser Trabeculoplasty Applied to 360° vs 180° of the Angle[J]. J Ophthalmol, 2021: 8860601.
[12]	Shibata M, Sugiyama T, Ishida O, et al. Clinical results of selective laser trabeculoplasty in open－angle glaucoma in Japanese eyes: comparison of 180 degree with 360 degree SLT[J]. J Glaucoma, 2012, 21(1): 17－21.
[13]	Prasad N, Murthy S, Dagianis JJ, et al. A comparison of the intervisit intraocular pressure fluctuation after 180 and 360 degrees of selective laser trabeculoplasty (SLT) as a primary therapy in primary open angle glaucoma and ocular hypertension[J]. J Glaucoma, 2009, 18(2): 157－160.
[14]	European Glaucoma Society Terminology Guidelines for Glaucoma, 5th Edition[J]. Br J Ophthalmol. 2021, 105(Suppl 1): 1－169.
[15]	Francis BA, Loewen N, Hong B, et al. Repeatability of selective laser trabeculoplasty for open－angle glaucoma[J]. BMC Ophthalmol, 2016, 16: 128.
[16]	Leahy KE, White AJ. Selective laser trabeculoplasty: current perspectives[J]. Clin Ophthalmol, 2015, 9: 833－841.
[17]	Lee JW, Ho WL, Chan JC, et al. Efficacy of selective laser trabeculoplasty for normal tension glaucoma: 1 year results[J]. BMC Ophthalmol, 2015, 15: 1.
[18]	Pillunat KR, Spoerl E, Elfes G, et al. Preoperative intraocular pressure as a predictor of selective laser trabeculoplasty efficacy[J]. Acta Ophthalmol, 2016, 94(7): 692－696.
[19]	Raj S, Tigari B, Faisal TT, et al. Efficacy of selective laser trabeculoplasty in primary angle closure disease[J]. Eye (Lond), 2018, 32(11): 1710－1716.
[20]	Aljasim LA, Owaidhah O, Edward DP. Selective Laser Trabeculoplasty in Primary Angle－closure Glaucoma After Laser Peripheral Iridotomy: A Case－Control Study[J]. J Glaucoma, 2016, 25(3): e253－258.
[21]	Lindegger DJ, Funk J, Jaggi GP. Long－term effect of selective laser trabeculoplasty on intraocular pressure in pseudoexfoliation glaucoma[J]. Klin Monbl Augenheilkd, 2015, 232(4): 405－408.
[22]	Kara N, Altan C, Yuksel K, et al. Comparison of the efficacy and safety of selective laser trabeculoplasty in cases with primary open－angle glaucoma and pseudoexfoliative glaucoma[J]. Kaohsiung J Med Sci, 2013, 29(9): 500－504.
[23]	Ilveskoski L, Taipale C, Tuuminen R. Selective laser trabeculoplasty in exfoliative glaucoma eyes with prior argon laser trabeculoplasty[J]. Acta Ophthalmol, 2020, 98(1): 58－64.
[24]	Ayala M. Long－term outcomes of selective laser trabeculoplasty (SLT) treatment in pigmentary glaucoma patients[J]. J Glaucoma, 2014, 23(9): 616－619.
[25]	Xiao J, Zhao C, Liang A, et al. Efficacy and Safety of High－Energy Selective Laser Trabeculoplasty for Steroid－Induced Glaucoma in Patients with Quiescent Uveitis[J]. Ocul Immunol Inflamm, 2020: 1－5.
[26]	Bozkurt E, Kara N, Yazici AT, et al. Prophylactic selective laser trabeculoplasty in the prevention of intraocular pressure elevation after intravitreal triamcinolone acetonide injection[J]. Am J Ophthalmol, 2011, 152(6): e972, e976－e981.
[27]	Zhang M, Li B, Wang J, et al. Clinical results of selective laser trabeculoplasty in silicone oil－induced secondary glaucoma[J]. Graefes Arch Clin Exp Ophthalmol, 2014, 252(6): 983－987.
[28]	张伟，谭海波. 选择性激光小梁成形术治疗硅油填充眼继发性青光眼[J]. 国际眼科杂志，2019，19(7)：1215－1217.
[29]	Nagar M, Ogunyomade A, O'Brart DP, et al. A randomised, prospective study comparing selective laser trabeculoplasty with latanoprost for the control of intraocular pressure in ocular hypertension and open angle glaucoma[J]. Br J Ophthalmol, 2005, 89(11): 1413－1417.
[30]	Nagar M, Luhishi E, Shah N. Intraocular pressure control and fluctuation: the effect of treatment with selective laser trabeculoplasty[J]. Br J Ophthalmol, 2009, 93(4): 497－501.
[31]	Kiddee W, Atthavuttisilp S. The effects of selective laser trabeculoplasty and travoprost on circadian intraocular pressure fluctuations: A randomized clinical trial[J]. Medicine (Baltimore), 2017, 96(6): e6047.
[32]	Ang GS, Fenwick EK, Constantinou M, et al. Selective laser trabeculoplasty versus topical medication as initial glaucoma treatment: the glaucoma initial treatment study randomised clinical trial[J]. Br J Ophthalmol, 2020, 104(6): 813－821.
[33]	Chi SC, Kang YN, Hwang DK, et al. Selective laser trabeculoplasty versus medication for open－angle glaucoma: systematic review and meta－analysis of randomised clinical trials[J]. Br J Ophthalmol, 2020, 104(11): 1500－1507.
[34]	Li X, Wang W, Zhang X. Meta－analysis of selective laser trabeculoplasty versus topical medication in the treatment of open－angle glaucoma[J]. BMC Ophthalmol, 2015, 15: 107.
[35]	Pahlitzsch M, Davids AM, Winterhalter S, et al. Selective Laser Trabeculoplasty Versus MIGS: Forgotten Art or First－Step Procedure in Selected Patients with Open－Angle Glaucoma[J]. Ophthalmol Ther, 2021, 10(3): 509－524.
[36]	Fea AM, Ahmed II, Lavia C, et al. Hydrus microstent compared to selective laser trabeculoplasty in primary open angle glaucoma[J]. Clin Exp Ophthalmol, 2017, 45(2): 120－127.
[37]	Katz LJ, Steinmann WC, Kabir A, et al. Selective laser trabeculoplasty versus medical therapy as initial treatment of glaucoma: a prospective, randomized trial[J]. J Glaucoma, 2012, 21(7): 460－468.
[38]	Lai JS, Chua JK, Tham CC, et al. Five－year follow up of selective laser trabeculoplasty in Chinese eyes[J]. Clin Exp Ophthalmol, 2004, 32(4): 368－372.
[39]	Wright DM, Konstantakopoulou E, Montesano G, et al. Visual Field Outcomes from the Multicenter, Randomized Controlled Laser in Glaucoma and Ocular Hypertension Trial (LiGHT)[J]. Ophthalmology, 2020, 127(10): 1313－1321.
[40]	Durr GM, Harasymowycz P. The effect of repeat 360－degree selective laser trabeculoplasty on intraocular pressure control in open－angle glaucoma[J]. J Fr Ophtalmol, 2016, 39(3): 261－264.
[41]	Garg A, Vickerstaff V, Nathwani N, et al. Efficacy of Repeat Selective Laser Trabeculoplasty in Medication－Naive Open－Angle Glaucoma and Ocular Hypertension during the LiGHT Trial[J]. Ophthalmology, 2020, 127(4): 467－476.
[42]	Polat J, Grantham L, Mitchell K, et al. Repeatability of selective laser trabeculoplasty[J]. Br J Ophthalmol, 2016, 100(10): 1437－1441.
[43]	Elahi S, Rao HL, Dumitru A, et al. Predictors of Success in Selective Laser Trabeculoplasty: Data From the Lausanne Laser Trabeculoplasty Registry[J]. J Glaucoma, 2020, 29(7): 550－555.
[44]	Gracner T, Naji M, Hudovernik M, et al. Predictive factors of successful selective laser trabeculoplasty in open－angle glaucoma[J]. Klin Monbl Augenheilkd, 2007, 224(12): 922－926.
[45]	Lee JW, Liu CC, Chan J, et al. Predictors of success in selective laser trabeculoplasty for primary open angle glaucoma in Chinese[J]. Clin Ophthalmol, 2014, 8: 1787－1791.
[46]	Bruen R, Lesk MR, Harasymowycz P. Baseline Factors Predictive of SLT Response: A Prospective Study[J]. J Ophthalmol, 2012: 642869.
[47]	Shazly TA, Latina MA, Dagianis JJ, et al. Effect of central corneal thickness on the long－term outcome of selective laser trabeculoplasty as primary treatment for ocular hypertension and primary open－angle glaucoma[J]. Cornea, 2012, 31(8): 883－886.
[48]	Kennedy JB, SooHoo JR, Kahook MY, et al. Selective Laser Trabeculoplasty: An Update[J]. Asia Pac J Ophthalmol (Phila), 2016, 5(1): 63－69.
[49]	Phillis CA, Bourke RD. Bilateral Subretinal Fluid Mimicking Subretinal Neovascularization Within 24 Hours After Selective Laser Trabeculoplasty[J]. J Glaucoma, 2016, 25(2): e110－e114.
[50]	Knickelbein JE, Singh A, Flowers BE, et al. Acute corneal edema with subsequent thinning and hyperopic shift following selective laser trabeculoplasty[J]. J Cataract Refract Surg, 2014, 40(10): 1731－1735.
[51]	Berdahl JP, Khatana AK, Katz LJ, et al. Cost－comparison of two trabecular micro－bypass stents versus selective laser trabeculoplasty or medications only for intraocular pressure control for patients with open－angle glaucoma[J]. J Med Econ, 2017, 20(7): 760－766.
[52]	Schultz NM, Wong WB, Coleman AL, et al. Predictors, Resource Utilization, and Short－term Costs of Laser Trabeculoplasty Versus Medication Management in Open－Angle Glaucoma[J]. Am J Ophthalmol, 2016, 168: 78－85.
[53]	Choi JA, Song LD, Choi S, et al. The cost－effectiveness of medication, laser trabeculoplasty, and trabeculectomy for treatment of open－angle glaucoma in South Korea[J]. Medicine (Baltimore), 2019, 98(2): e14026.
[54]	Keyser MD, Belder MD, Groot VD. Quality of life in glaucoma patients after selective laser trabeculoplasty[J]. Int J Ophthalmol, 2017, 10(5): 742－748.
[55]	Zhou R, Sun Y, Chen H, et al. Laser Trabeculoplasty for Open－Angle Glaucoma: A Systematic Review and Network Meta－Analysis[J]. Am J Ophthalmol, 2021, 229: 301－313.

Please choose a citation manager

Content to export